Two-component Signaling Pathways: A bacterial Goldilocks mechanism
When mollusks get bigger, their shells grow with them to accommodate the changing shape and size of the organism being housed. Something similar also happens in bacteria. The cell wall of most bacteria consists of a single macromolecule called peptidoglycan that surrounds the cell and is made up of modified sugars that are crosslinked through peptide side chains. Like sea shells, bacteria come in different sizes and the cell wall dictates their shape (Cabeen and Jacobs-Wagner, 2007). The cell wall also protects bacteria from adverse environmental conditions, but it must be constantly remodeled so that rapid bacterial growth and division can take place. The enzymes in charge of this remodeling process are called autolysins, and their activity must be regulated to stop bacteria from losing their cell wall.
Signal transduction systems are protein systems that detect molecular or physical cues and translate them into an appropriate cellular response. In bacteria, signal transduction is commonly regulated by two-component systems, known as TCS for short (Zschiedrich et al., 2016). Usually the two components are a signal detector and a transcription factor that communicate with one another through the transfer of a phosphoryl group.
An important TCS in the soil bacterium Bacillus subtilis and other related bacteria is the WalRK system, which is essential for viability (Szurmant, 2012). The system, which is comprised of the signal-detecting protein WalK and the transcription factor WalR, gets its name from its role in maintaining the cell wall (Dubrac et al., 2007). Together these two components regulate the expression of several autolysin genes, including those for the enzymes LytE and CwlO, which are required for cell elongation (Salzberg et al., 2013). Now, in eLife, David Rudner and colleagues at Harvard Medical School – including Genevieve Dobihal and Yannick Brunet as joint first authors, along with Josué Flores-Kim – report on how the WalRK system in B. subtilis detects and responds to autolysin levels (Dobihal et al., 2019).
Dobihal et al. first observed that B. subtilis can measure the levels of autolysin activity and, if they are too low for the cell to grow, can adjust them accordingly. Next, they examined if the reverse is also true: can the cell identify if autolysin activity is too high to retain the protective shell, and reduce autolysin expression appropriately? Indeed, when the autolysin LytE is artificially overproduced, the cell reduces endogenous production of this enzyme. Thus the bacterium employs homeostatic control to ensure that autolysin activity is 'not too much, not too little, but just right', just like in the tale of Goldilocks and the three bears (Figure 1). This equilibrium is important given that mis-regulated autolysin activity can lead to cell lysis and defects in the permeability of the membrane.

The Goldilocks principle applied to bacterial cell wall homeostasis.
The bacterial cell wall (top left) consists of sugar strands (hexagons) that are crosslinked via peptide bonds between their peptide sidechains (small circles). Cell expansion requires the incorporation of new cell wall material. Autolysin enzymes cleave the peptide crosslinks to allow for expansion. Insufficient autolysin activity prevents expansion and thus growth (bottom left). Uncontrolled autolysin activity results in cell wall destruction and lysis (indicated by yellow stars, top right). When the autolysin activity is ‘just right’, the cell wall expands (red) and its integrity is maintained (bottom right).
Dobihal et al. then used several reporters to measure the expression of different genes regulated by WalR, and found they all responded similarly to the overexpression and deletion of the gene for LytE. This suggests that LytE and CwlO activity is directly detected by the WalRK system, but the precise signal used by the WalRK system to detect this activity remained unknown, as did the mechanism of detection.
WalK is a multi-domain membrane-spanning protein that has two domains commonly associated with signal detection: one of these domains faces the outside of the cell whereas the other faces the inside (Fukushima et al., 2011). WalK interacts with two other proteins that inhibit its activity, WalH and WalI (Szurmant et al., 2007; Szurmant et al., 2008). The signal for autolysin levels could be perceived by either of the two inhibitor proteins or by one of the signal detection domains of WalK. Dobihal et al. deleted domains in WalH, WalI and WalK to determine which protein detected the signal, demonstrating that the WalK domain that faces the outside of the cell is the only one required.
But what is the signal detected by WalK? LytE and CwlO are both able to cleave peptide bonds, probably to reduce crosslinks in the cell wall (Bisicchia et al., 2007). WalK could therefore be responding to a physical signal, such as a change in the tension exerted by a cell wall with too many or too few crosslinks. Alternatively, the signal could be of a chemical nature, such as a peptide being released when the autolysins remodel the cell wall. To distinguish between these two possibilities, Dobihal et al. exposed the purified cell wall of B. subtilis to the CwlO enzyme in vitro, and then applied the cleavage products of the reaction to B. subtilis cultures. The results showed that the cleavage products of CwlO can affect the expression of genes regulated by WalR. Exactly which molecule interacts with WalK to relay the signal remains unknown.
The findings by Dobihal et al. contribute to our understanding of the WalRK two-component system in B. subtilis. The spherical bacteria Staphylococcus aureus and Streptococcus pneumoniae are distant relatives of B. subtilis and also use the WalRK system to modulate autolysin gene expression, despite not growing by cell wall elongation (Ng and Winkler, 2004; Dubrac et al., 2007). Differences in domain architecture of WalK (S. pneumoniae) or cell wall crosslinks (S. aureus) dictate that the signal to modulate WalRK activity must be different from the one used by B. subtilis. Even in B. subtilis previous results suggested that there might be additional signals detected by WalK that are related to cell division (Fukushima et al., 2011). Thus, a unifying theme for the role of WalRK in all these bacteria remains unclear, and requires additional studies to build on these exciting new insights.
References
-
Skin and bones: the bacterial cytoskeleton, cell wall, and cell morphogenesisThe Journal of Cell Biology 179:381–387.https://doi.org/10.1083/jcb.200708001
-
A role for the essential YycG sensor histidine kinase in sensing cell divisionMolecular Microbiology 79:503–522.https://doi.org/10.1111/j.1365-2958.2010.07464.x
-
YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilisJournal of Bacteriology 189:3280–3289.https://doi.org/10.1128/JB.01936-06
-
BookEssential two-component systems of gram-positive bacteriaIn: Gross R, Beier D, editors. Two-Component Systems in Bacteria, 1. Norwich: Caister Scientific Press. pp. 127–147.
-
Molecular mechanisms of two-component signal transductionJournal of Molecular Biology 428:3752–3775.https://doi.org/10.1016/j.jmb.2016.08.003
Article and author information
Author details
Publication history
Copyright
© 2020, Kim and Szurmant
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,013
- views
-
- 171
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Immunology and Inflammation
- Microbiology and Infectious Disease
Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that displays great variability in clinical phenotype. Many factors have been described to be correlated with its severity, and microbiota could play a key role in the infection, progression, and outcome of the disease. SARS-CoV-2 infection has been associated with nasopharyngeal and gut dysbiosis and higher abundance of opportunistic pathogens. To identify new prognostic markers for the disease, a multicentre prospective observational cohort study was carried out in COVID-19 patients divided into three cohorts based on symptomatology: mild (n = 24), moderate (n = 51), and severe/critical (n = 31). Faecal and nasopharyngeal samples were taken, and the microbiota was analysed. Linear discriminant analysis identified Mycoplasma salivarium, Prevotella dentalis, and Haemophilus parainfluenzae as biomarkers of severe COVID-19 in nasopharyngeal microbiota, while Prevotella bivia and Prevotella timonensis were defined in faecal microbiota. Additionally, a connection between faecal and nasopharyngeal microbiota was identified, with a significant ratio between P. timonensis (faeces) and P. dentalis and M. salivarium (nasopharyngeal) abundances found in critically ill patients. This ratio could serve as a novel prognostic tool for identifying severe COVID-19 cases.
-
- Epidemiology and Global Health
- Microbiology and Infectious Disease
Background:
In many settings, a large fraction of the population has both been vaccinated against and infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, quantifying the protection provided by post-infection vaccination has become critical for policy. We aimed to estimate the protective effect against SARS-CoV-2 reinfection of an additional vaccine dose after an initial Omicron variant infection.
Methods:
We report a retrospective, population-based cohort study performed in Shanghai, China, using electronic databases with information on SARS-CoV-2 infections and vaccination history. We compared reinfection incidence by post-infection vaccination status in individuals initially infected during the April–May 2022 Omicron variant surge in Shanghai and who had been vaccinated before that period. Cox models were fit to estimate adjusted hazard ratios (aHRs).
Results:
275,896 individuals were diagnosed with real-time polymerase chain reaction-confirmed SARS-CoV-2 infection in April–May 2022; 199,312/275,896 were included in analyses on the effect of a post-infection vaccine dose. Post-infection vaccination provided protection against reinfection (aHR 0.82; 95% confidence interval 0.79–0.85). For patients who had received one, two, or three vaccine doses before their first infection, hazard ratios for the post-infection vaccination effect were 0.84 (0.76–0.93), 0.87 (0.83–0.90), and 0.96 (0.74–1.23), respectively. Post-infection vaccination within 30 and 90 days before the second Omicron wave provided different degrees of protection (in aHR): 0.51 (0.44–0.58) and 0.67 (0.61–0.74), respectively. Moreover, for all vaccine types, but to different extents, a post-infection dose given to individuals who were fully vaccinated before first infection was protective.
Conclusions:
In previously vaccinated and infected individuals, an additional vaccine dose provided protection against Omicron variant reinfection. These observations will inform future policy decisions on COVID-19 vaccination in China and other countries.
Funding:
This study was funded the Key Discipline Program of Pudong New Area Health System (PWZxk2022-25), the Development and Application of Intelligent Epidemic Surveillance and AI Analysis System (21002411400), the Shanghai Public Health System Construction (GWVI-11.2-XD08), the Shanghai Health Commission Key Disciplines (GWVI-11.1-02), the Shanghai Health Commission Clinical Research Program (20214Y0020), the Shanghai Natural Science Foundation (22ZR1414600), and the Shanghai Young Health Talents Program (2022YQ076).